Since the advent of additive manufacturing, known commonly as 3D printing, this technology
has revolutionized the biofabrication landscape and driven numerous pivotal advancements …

Synthetic biodegradable elastomers, such as polyesters and polyurethanes have
revolutionized biomedical therapeutic strategies and devices. Driven by innovations in …

A significant challenge in cardiac tissue engineering is the development of biomimetic grafts
that can potentially promote myocardial repair and regeneration. A number of approaches …

Elastin and collagen are the two main components of elastic tissues and provide the tissue
with elasticity and mechanical strength, respectively. Whereas collagen is adequately …

Valvular heart diseases (VHD) are a major health burden, affecting millions of people
worldwide. The treatments for such diseases rely on medicine, valve repair, and artificial …

The current clinical solutions, including mechanical and bioprosthetic valves for valvular
heart diseases, are plagued by coagulation, calcification, nondurability, and the inability to …

Tissue engineered heart valves offer a promising alternative for the replacement of diseased
heart valves avoiding the limitations faced with currently available bioprosthetic and …

Tissue engineered heart valves (TEHVs) that can grow and remodel have the potential to
serve as permanent replacements of the current non-viable prosthetic valves particularly for …

The evolution of micro and nanofabrication approaches significantly spurred the
advancements of cardiac tissue engineering over the last decades. Engineering in the micro …

Cardiovascular diseases (CVDs) are known as the major cause of death worldwide. In spite
of tremendous advancements in medical therapy, the gold standard for CVD treatment is still …